XGEVA taking over

[Anonymous]

Already Amgen has reimbursement in US oncology where Zometa doesn't. Maybe if we had not laid off so many reps and not spent that money on Riva's Italian pleausre cruise for adepartment meeting we could have save 30 million in Zometa sales first quarter.

Maybe.

 

[Anonymous]

Your key word in post is "Maybe" Novartis can't get anything right! I could go on and on, but why repeat the obvious! Let's see... a new challenger in town and lay offs! Really? So let's just role over and play dead! This division just can't figure things out. Kristi leaves a message that we met goals and have great growth, but not in the US! Why do you set goals so we can't meet them? Ugh